首页 > 最新文献

Klinische Monatsblatter fur Augenheilkunde最新文献

英文 中文
Topical Atropine for Myopia Control: A Review. 控制近视的局部阿托品:综述。
IF 0.8 4区 医学 Q4 OPHTHALMOLOGY Pub Date : 2024-10-01 Epub Date: 2024-05-27 DOI: 10.1055/a-2307-0363
Navid Farassat

Over the past decade, atropine has emerged as an effective intervention for preventing myopia in children. Multiple randomized controlled trials, mainly from Asia, have demonstrated the safety and efficacy of topical atropine for myopia control. Both efficacy and side effects exhibit a positive dose-response relationship. This review focuses on new data from studies with predominantly white populations, ethnicity-dependent differences in efficacy and side effects, and primary prevention of incident myopia with atropine.

在过去十年中,阿托品已成为预防儿童近视的有效干预措施。主要来自亚洲的多项随机对照试验证明了局部使用阿托品控制近视的安全性和有效性。疗效和副作用都呈现出剂量-反应的正相关关系。本综述重点关注以白人为主的研究中的新数据、疗效和副作用方面的种族差异,以及使用阿托品对近视进行一级预防。
{"title":"Topical Atropine for Myopia Control: A Review.","authors":"Navid Farassat","doi":"10.1055/a-2307-0363","DOIUrl":"10.1055/a-2307-0363","url":null,"abstract":"<p><p>Over the past decade, atropine has emerged as an effective intervention for preventing myopia in children. Multiple randomized controlled trials, mainly from Asia, have demonstrated the safety and efficacy of topical atropine for myopia control. Both efficacy and side effects exhibit a positive dose-response relationship. This review focuses on new data from studies with predominantly white populations, ethnicity-dependent differences in efficacy and side effects, and primary prevention of incident myopia with atropine.</p>","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":"1134-1139"},"PeriodicalIF":0.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anstieg an Fällen periorbitaler nekrotisierender Fasziitis. 眶周坏死性筋膜炎病例增加。
IF 0.8 4区 医学 Q4 OPHTHALMOLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-09 DOI: 10.1055/a-2350-3540
Anna Schuh, Christoph Hintschich, Siegfried Priglinger
{"title":"Anstieg an Fällen periorbitaler nekrotisierender Fasziitis.","authors":"Anna Schuh, Christoph Hintschich, Siegfried Priglinger","doi":"10.1055/a-2350-3540","DOIUrl":"https://doi.org/10.1055/a-2350-3540","url":null,"abstract":"","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":"241 10","pages":"1114-1116"},"PeriodicalIF":0.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multifocal Optics for Myopia Control. 控制近视的多焦光学技术
IF 0.8 4区 医学 Q4 OPHTHALMOLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-09 DOI: 10.1055/a-2397-1660
Christine Schmucker, Wolf Alexander Lagrèze

The rising prevalence of myopia among children and adolescents necessitates effective interventions to mitigate long-term risks, such as retinal detachment and macular degeneration. Traditional approaches like undercorrection with single-vision lenses have proven ineffective. Recent research underscores the significance of peripheral vision in managing myopia progression. While hyperopic defocus in the peripheral retina may encourage axial elongation, multifocal lenses designed to induce peripheral myopic defocus can potentially curb this elongation. Randomized controlled trials (RCTs) have demonstrated that spectacle lenses with peripheral modifications, such as highly aspherical lenslets (HAL) or defocus incorporated multiple segments (DIMS), reduce myopia progression and axial elongation over 2 years. Similarly, multifocal contact lenses, especially those with high-add power (+ 2.50 D), have shown comparable reductions over 3 years. Safety is a critical consideration in myopia control. Multifocal spectacle lenses with peripheral plus designs are generally well tolerated, with only transient side effects, like dizziness and blurred vision. Soft multifocal contact lenses also exhibit a favorable safety profile, with low rates of serious adverse events. Thorough monitoring and reporting in these studies are essential to provide assurance about the safety of these interventions for children. Future research should aim to include more diverse populations in order to ensure the generalizability of findings across various demographic groups. Additionally, real-world data would offer valuable insights into the performance of these treatments in everyday scenarios. Observational studies, less influenced by industry sponsorship, could further validate these findings. Lastly, the clinical significance of the observed effects should be critically assessed to confirm that the reported benefits lead to meaningful reductions in myopia progression.

随着儿童和青少年近视发病率的上升,有必要采取有效的干预措施,以降低视网膜脱离和黄斑变性等长期风险。事实证明,使用单焦镜片进行欠矫治等传统方法效果不佳。最新研究强调了周边视力对控制近视发展的重要性。周边视网膜的远视散焦可能会促进轴向拉长,而设计用于诱导周边近视散焦的多焦点镜片则有可能抑制这种拉长。随机对照试验(RCTs)证明,镜片外围经过改良(如高非球面镜片(HAL)或多节散焦镜片(DIMS)),可在两年内减少近视度数加深和眼轴拉长。同样,多焦点隐形眼镜,尤其是那些具有高加力(+ 2.50 D)的隐形眼镜,在 3 年内也显示出了类似的降低效果。安全是控制近视的关键因素。采用周边加力设计的多焦点镜片一般耐受性良好,只有短暂的副作用,如头晕和视力模糊。软性多焦点隐形眼镜也表现出良好的安全性,严重不良反应发生率较低。要确保这些干预措施对儿童的安全性,就必须对这些研究进行彻底的监测和报告。未来的研究应旨在纳入更多不同的人群,以确保研究结果在不同人群中的普遍性。此外,真实世界的数据将为了解这些治疗方法在日常生活中的表现提供宝贵的信息。受行业赞助影响较小的观察性研究可以进一步验证这些发现。最后,应对观察到的效果的临床意义进行严格评估,以确认所报告的疗效是否能有效降低近视度数的加深。
{"title":"Multifocal Optics for Myopia Control.","authors":"Christine Schmucker, Wolf Alexander Lagrèze","doi":"10.1055/a-2397-1660","DOIUrl":"https://doi.org/10.1055/a-2397-1660","url":null,"abstract":"<p><p>The rising prevalence of myopia among children and adolescents necessitates effective interventions to mitigate long-term risks, such as retinal detachment and macular degeneration. Traditional approaches like undercorrection with single-vision lenses have proven ineffective. Recent research underscores the significance of peripheral vision in managing myopia progression. While hyperopic defocus in the peripheral retina may encourage axial elongation, multifocal lenses designed to induce peripheral myopic defocus can potentially curb this elongation. Randomized controlled trials (RCTs) have demonstrated that spectacle lenses with peripheral modifications, such as highly aspherical lenslets (HAL) or defocus incorporated multiple segments (DIMS), reduce myopia progression and axial elongation over 2 years. Similarly, multifocal contact lenses, especially those with high-add power (+ 2.50 D), have shown comparable reductions over 3 years. Safety is a critical consideration in myopia control. Multifocal spectacle lenses with peripheral plus designs are generally well tolerated, with only transient side effects, like dizziness and blurred vision. Soft multifocal contact lenses also exhibit a favorable safety profile, with low rates of serious adverse events. Thorough monitoring and reporting in these studies are essential to provide assurance about the safety of these interventions for children. Future research should aim to include more diverse populations in order to ensure the generalizability of findings across various demographic groups. Additionally, real-world data would offer valuable insights into the performance of these treatments in everyday scenarios. Observational studies, less influenced by industry sponsorship, could further validate these findings. Lastly, the clinical significance of the observed effects should be critically assessed to confirm that the reported benefits lead to meaningful reductions in myopia progression.</p>","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":"241 10","pages":"1129-1133"},"PeriodicalIF":0.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Current Artificial Intelligence Programs on the Knowledge of Glaucoma. 评估当前有关青光眼知识的人工智能程序。
IF 0.8 4区 医学 Q4 OPHTHALMOLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-24 DOI: 10.1055/a-2327-8484
Eyupcan Sensoy, Mehmet Citirik

Background: To measure the success of three different artificial intelligence chatbots, ChatGPT, Bard, and Bing, in correctly answering questions about glaucoma types and treatment modalities and to examine their superiority over each other.

Materials and methods: Thirty-two questions about glaucoma types and treatment modalities were asked using the ChatGPT, Bard, and Bing chatbots. The correct and incorrect answers were also provided. Accuracy rates were compared.

Outcomes: Questions asked: ChatGPT answered 56.3%, Bard 78.1%, and Bing 59.4% correctly. There was no statistically significant difference between the three artificial intelligence chatbots in the rate of correct and incorrect answers to the questions asked (p = 0.195).

Conclusion: Artificial intelligence chatbots can be used as a tool to access accurate information regarding glaucoma types and treatment modalities. However, the information obtained is not always accurate, and care should be taken when using this information.

背景:测量 ChatGPT、Bard 和 Bing 这三种不同的人工智能聊天机器人在正确回答有关青光眼类型和治疗方式的问题方面的成功率,并研究它们之间的优劣:使用 ChatGPT、Bard 和 Bing 聊天机器人提出了 32 个有关青光眼类型和治疗方式的问题。同时还提供了正确答案和错误答案。比较了准确率:所提问题:ChatGPT 回答正确率为 56.3%,Bard 为 78.1%,Bing 为 59.4%。三个人工智能聊天机器人回答问题的正确率和错误率在统计学上没有明显差异(p = 0.195):人工智能聊天机器人可用作获取有关青光眼类型和治疗方式的准确信息的工具。结论:人工智能聊天机器人可作为获取有关青光眼类型和治疗方式的准确信息的工具,但获取的信息并不总是准确的,因此在使用这些信息时应谨慎。
{"title":"Evaluation of Current Artificial Intelligence Programs on the Knowledge of Glaucoma.","authors":"Eyupcan Sensoy, Mehmet Citirik","doi":"10.1055/a-2327-8484","DOIUrl":"10.1055/a-2327-8484","url":null,"abstract":"<p><strong>Background: </strong>To measure the success of three different artificial intelligence chatbots, ChatGPT, Bard, and Bing, in correctly answering questions about glaucoma types and treatment modalities and to examine their superiority over each other.</p><p><strong>Materials and methods: </strong>Thirty-two questions about glaucoma types and treatment modalities were asked using the ChatGPT, Bard, and Bing chatbots. The correct and incorrect answers were also provided. Accuracy rates were compared.</p><p><strong>Outcomes: </strong>Questions asked: ChatGPT answered 56.3%, Bard 78.1%, and Bing 59.4% correctly. There was no statistically significant difference between the three artificial intelligence chatbots in the rate of correct and incorrect answers to the questions asked (p = 0.195).</p><p><strong>Conclusion: </strong>Artificial intelligence chatbots can be used as a tool to access accurate information regarding glaucoma types and treatment modalities. However, the information obtained is not always accurate, and care should be taken when using this information.</p>","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":"1140-1144"},"PeriodicalIF":0.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141759577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Celebrating 25 Years of Optical Biometry: A Milestone in Ophthalmology. 庆祝光学生物测量 25 周年:眼科学的里程碑。
IF 0.8 4区 医学 Q4 OPHTHALMOLOGY Pub Date : 2024-10-01 DOI: 10.1055/a-2428-8007
Sibylle Katharina Scholtz, Achim Langenbucher, Oliver Stachs
{"title":"Celebrating 25 Years of Optical Biometry: A Milestone in Ophthalmology.","authors":"Sibylle Katharina Scholtz, Achim Langenbucher, Oliver Stachs","doi":"10.1055/a-2428-8007","DOIUrl":"https://doi.org/10.1055/a-2428-8007","url":null,"abstract":"","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eye Injury Incidence in Germany from 2008 to 2022: An Analysis of Hospital Quality Reports. 2008 至 2022 年德国眼外伤发生率:医院质量报告分析。
IF 0.8 4区 医学 Q4 OPHTHALMOLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-09 DOI: 10.1055/a-2364-2461
Stefan J Lang, Daniel Böhringer, Hansjürgen Agostini, Martin Kuklinski, Thomas Reinhard, Annette Sturm, Hien Le-Deffge, Amelie Gabel-Pfisterer

Background: Eye injuries range from minor to severe and may lead to permanent visual impairment. There is still little in the way of epidemiological data on eye injuries in Germany.

Aim: The aim of this study was to obtain an objective record of minor and severe eye injuries in Germany by evaluating hospital quality reports. We also investigated the relevance of injuries from fireworks in relation to the total number of eye injuries and the general population.

Methods: This retrospective routine data study entailed analysing hospital quality reports from 2008 to 2022 in XML format. The R programming language was used for data processing and statistical analysis. The number of ICD-coded eye injuries was exported and analysed together with location data. We also included data from a prospective survey study on fireworks-related eye injuries from 2016 to 2023.

Results: Eyeball and/or orbital contusions are the most common eye injuries treated in Germany at up to 2,500 cases per year. The most severe injuries comprise traumatic globe rupture with loss of intraocular tissue at up to 990 cases per year. Numbers of eye injuries of any type have been declining since 2020. As a percentage of population, Mecklenburg-Western Pomerania treats the most eye injuries at up to 0.017%; in absolute numbers, North Rhine-Westphalia leads the country at up to 1,600 injuries. Private firework displays are probably responsible for 1.4% of annual globe ruptures and 8.3% of eyeball contusions.

Conclusion: Our analysis of hospital quality reports has provided the first comprehensive epidemiological record on eye injuries in Germany. Firework-related injuries account for a relevant proportion of total injuries. These results could serve as a basis for preventive measures and health policy decisions.

背景:眼外伤的程度从轻微到严重不等,并可能导致永久性视力损伤。目的:本研究旨在通过评估医院质量报告,客观记录德国轻微和严重眼外伤的情况。我们还调查了烟花爆竹造成的伤害与眼外伤总数和总人口的相关性:这项回顾性常规数据研究需要分析 2008 年至 2022 年期间 XML 格式的医院质量报告。数据处理和统计分析采用 R 编程语言。我们将 ICD 编码的眼外伤数量与位置数据一起导出并进行分析。我们还纳入了 2016 年至 2023 年烟花爆竹相关眼外伤前瞻性调查研究的数据:在德国,眼球和/或眼眶挫伤是最常见的眼部损伤,每年高达 2,500 例。最严重的伤害包括外伤性眼球破裂和眼内组织损失,每年高达 990 例。自 2020 年以来,各种类型的眼外伤数量一直在下降。就人口比例而言,梅克伦堡-西波美拉尼亚州治疗的眼外伤最多,高达 0.017%;就绝对数字而言,北莱茵-威斯特法伦州居全国之首,高达 1,600 例。每年1.4%的眼球破裂和8.3%的眼球挫伤可能是私人烟花表演造成的:我们对医院质量报告的分析首次提供了德国眼外伤的全面流行病学记录。与火灾相关的伤害在总伤害中占有一定比例。这些结果可作为预防措施和卫生政策决策的依据。
{"title":"Eye Injury Incidence in Germany from 2008 to 2022: An Analysis of Hospital Quality Reports.","authors":"Stefan J Lang, Daniel Böhringer, Hansjürgen Agostini, Martin Kuklinski, Thomas Reinhard, Annette Sturm, Hien Le-Deffge, Amelie Gabel-Pfisterer","doi":"10.1055/a-2364-2461","DOIUrl":"https://doi.org/10.1055/a-2364-2461","url":null,"abstract":"<p><strong>Background: </strong>Eye injuries range from minor to severe and may lead to permanent visual impairment. There is still little in the way of epidemiological data on eye injuries in Germany.</p><p><strong>Aim: </strong>The aim of this study was to obtain an objective record of minor and severe eye injuries in Germany by evaluating hospital quality reports. We also investigated the relevance of injuries from fireworks in relation to the total number of eye injuries and the general population.</p><p><strong>Methods: </strong>This retrospective routine data study entailed analysing hospital quality reports from 2008 to 2022 in XML format. The R programming language was used for data processing and statistical analysis. The number of ICD-coded eye injuries was exported and analysed together with location data. We also included data from a prospective survey study on fireworks-related eye injuries from 2016 to 2023.</p><p><strong>Results: </strong>Eyeball and/or orbital contusions are the most common eye injuries treated in Germany at up to 2,500 cases per year. The most severe injuries comprise traumatic globe rupture with loss of intraocular tissue at up to 990 cases per year. Numbers of eye injuries of any type have been declining since 2020. As a percentage of population, Mecklenburg-Western Pomerania treats the most eye injuries at up to 0.017%; in absolute numbers, North Rhine-Westphalia leads the country at up to 1,600 injuries. Private firework displays are probably responsible for 1.4% of annual globe ruptures and 8.3% of eyeball contusions.</p><p><strong>Conclusion: </strong>Our analysis of hospital quality reports has provided the first comprehensive epidemiological record on eye injuries in Germany. Firework-related injuries account for a relevant proportion of total injuries. These results could serve as a basis for preventive measures and health policy decisions.</p>","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":"241 10","pages":"1145-1155"},"PeriodicalIF":0.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From Trial to Trial: Diminishing Effects Sizes of Interventions for Myopia Control - a Call for Critical Reassessment. 从试验到试验:近视控制干预措施的效应大小递减--呼吁进行严格的重新评估。
IF 0.8 4区 医学 Q4 OPHTHALMOLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-09 DOI: 10.1055/a-2340-8299
Wolf Lagrèze
{"title":"From Trial to Trial: Diminishing Effects Sizes of Interventions for Myopia Control - a Call for Critical Reassessment.","authors":"Wolf Lagrèze","doi":"10.1055/a-2340-8299","DOIUrl":"https://doi.org/10.1055/a-2340-8299","url":null,"abstract":"","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":"241 10","pages":"1117-1118"},"PeriodicalIF":0.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chromatic Light Therapy for Inhibiting Myopia Progression: Human Studies. 抑制近视发展的色光疗法:人体研究。
IF 0.8 4区 医学 Q4 OPHTHALMOLOGY Pub Date : 2024-10-01 Epub Date: 2024-05-09 DOI: 10.1055/a-2322-9892
Barbara Swiatczak

Myopia, a common refractive error, has been associated with various risk factors, but time outdoors has emerged as a significant protective factor against its onset. This association is believed to be mediated by the influence of sunlight on dopamine release, a neurotransmitter crucial for regulating eye growth. Recent research has explored the specific properties of light in order to identify potential interventions for myopia control in children. Low-level red light therapy has gained attention, and has shown promise in inhibiting myopia progression, although there are concerns about safety and rebound effects. Similarly, blue light stimulation aims to upregulate retinal dopamine activity, yet conclusive evidence supporting its efficacy is lacking. Moreover, researchers explored the use of the entire visible light spectrum by digitally imposing longitudinal chromatic aberration to adjust proper eye growth. Preliminary findings suggest that digitally simulated chromatic aberration could potentially serve as a myopia control strategy and highlights the need for further investigation into long-term effects. As research progresses, understanding the efficacy and safety of light-based interventions for myopia control remains crucial for informing clinical practice and optimizing patient outcomes.

近视是一种常见的屈光不正,与各种风险因素有关,但户外活动时间是防止近视发生的重要保护因素。这种关联被认为是由阳光对多巴胺释放的影响介导的,多巴胺是一种对调节眼睛生长至关重要的神经递质。最近的研究探索了光的特殊属性,以确定控制儿童近视的潜在干预措施。低强度红光疗法受到了关注,并显示出抑制近视发展的前景,但人们对其安全性和反弹效应表示担忧。同样,蓝光刺激的目的是提高视网膜多巴胺的活性,但目前还缺乏支持其疗效的确凿证据。此外,研究人员还探索了利用整个可见光光谱,通过数字技术施加纵向色差来调整眼睛的正常发育。初步研究结果表明,数字模拟色差有可能成为一种近视控制策略,并强调了进一步研究其长期效果的必要性。随着研究的深入,了解基于光的近视控制干预措施的有效性和安全性对于指导临床实践和优化患者治疗效果至关重要。
{"title":"Chromatic Light Therapy for Inhibiting Myopia Progression: Human Studies.","authors":"Barbara Swiatczak","doi":"10.1055/a-2322-9892","DOIUrl":"10.1055/a-2322-9892","url":null,"abstract":"<p><p>Myopia, a common refractive error, has been associated with various risk factors, but time outdoors has emerged as a significant protective factor against its onset. This association is believed to be mediated by the influence of sunlight on dopamine release, a neurotransmitter crucial for regulating eye growth. Recent research has explored the specific properties of light in order to identify potential interventions for myopia control in children. Low-level red light therapy has gained attention, and has shown promise in inhibiting myopia progression, although there are concerns about safety and rebound effects. Similarly, blue light stimulation aims to upregulate retinal dopamine activity, yet conclusive evidence supporting its efficacy is lacking. Moreover, researchers explored the use of the entire visible light spectrum by digitally imposing longitudinal chromatic aberration to adjust proper eye growth. Preliminary findings suggest that digitally simulated chromatic aberration could potentially serve as a myopia control strategy and highlights the need for further investigation into long-term effects. As research progresses, understanding the efficacy and safety of light-based interventions for myopia control remains crucial for informing clinical practice and optimizing patient outcomes.</p>","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":"1126-1128"},"PeriodicalIF":0.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of Myopia: Prevalence, Risk Factors and Effects of Myopia. 近视的流行病学:近视的发病率、风险因素和影响。
IF 0.8 4区 医学 Q4 OPHTHALMOLOGY Pub Date : 2024-10-01 Epub Date: 2024-10-09 DOI: 10.1055/a-2340-1790
Susanne Hopf, Alexander Schuster

Myopia is the most common cause of visual impairment in children and young adults. In order to assess the consequences for society, it is necessary to know temporal trends in prevalence, incidence and associated factors in childhood and adolescence, as well as the rate of myopia progression, as based on epidemiological research. This paper presents a literature review of publications from 2020 up to March 2024, supplemented by other relevant publications. The prevalence of myopia in children and adolescents in Germany is almost stable and is significantly lower than in Asia. The development of myopia is influenced by outdoor activity, parental myopia, genetics and near work, while insufficient time spent outdoors in childhood is a significant and controllable risk factor for myopia-related complications such as myopic maculopathy, glaucoma, and retinal detachment.

近视是儿童和青少年视力受损的最常见原因。为了评估近视对社会造成的影响,有必要根据流行病学研究,了解儿童和青少年时期近视流行率、发病率和相关因素的时间趋势,以及近视发展的速度。本文对 2020 年至 2024 年 3 月期间的出版物进行了文献综述,并对其他相关出版物进行了补充。德国儿童和青少年的近视发病率基本保持稳定,明显低于亚洲。近视的发展受户外活动、父母近视、遗传和近距离工作的影响,而儿童时期户外活动时间不足是近视相关并发症(如近视性黄斑病变、青光眼和视网膜脱离)的一个重要且可控的风险因素。
{"title":"Epidemiology of Myopia: Prevalence, Risk Factors and Effects of Myopia.","authors":"Susanne Hopf, Alexander Schuster","doi":"10.1055/a-2340-1790","DOIUrl":"https://doi.org/10.1055/a-2340-1790","url":null,"abstract":"<p><p>Myopia is the most common cause of visual impairment in children and young adults. In order to assess the consequences for society, it is necessary to know temporal trends in prevalence, incidence and associated factors in childhood and adolescence, as well as the rate of myopia progression, as based on epidemiological research. This paper presents a literature review of publications from 2020 up to March 2024, supplemented by other relevant publications. The prevalence of myopia in children and adolescents in Germany is almost stable and is significantly lower than in Asia. The development of myopia is influenced by outdoor activity, parental myopia, genetics and near work, while insufficient time spent outdoors in childhood is a significant and controllable risk factor for myopia-related complications such as myopic maculopathy, glaucoma, and retinal detachment.</p>","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":"241 10","pages":"1119-1125"},"PeriodicalIF":0.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence in neovascular age-related macular degeneration. 人工智能在新生血管性老年黄斑变性中的应用。
IF 0.8 4区 医学 Q4 OPHTHALMOLOGY Pub Date : 2024-09-11 DOI: 10.1055/a-2413-6782
Lorenzo Ferro Desideri, Martin Zinkernagel, Rodrigo Anguita
{"title":"Artificial Intelligence in neovascular age-related macular degeneration.","authors":"Lorenzo Ferro Desideri, Martin Zinkernagel, Rodrigo Anguita","doi":"10.1055/a-2413-6782","DOIUrl":"https://doi.org/10.1055/a-2413-6782","url":null,"abstract":"","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142290303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Klinische Monatsblatter fur Augenheilkunde
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1